← Back to Dashboard

HIV-1

Retroviridae · Lentivirus

Pandemic potential
36
Approved Drugs
4
Phase 3
18
Phase 2
48
Preclinical
106
Total Compounds

Antiviral Compounds

InosineHIV-1Stimulates cell-mediated immune response
Preclinical
Viral RT
LopinavirHIV-1HIV protease inhibitor
FDA approved
FDAJapanRussia
Viral protease
NelfinavirHIV-1HIV protease inhibitor
FDA approved
FDAJapan
Viral protease
RitonavirHIV-1HIV protease inhibitor
FDA approved
FDAJapanRussia
Viral protease
TenofovirHIV-1Nucleotide analog RT inhibitor
FDA approved
FDAChinaRussia
Viral RT
RDEA806HIV-1
Phase 2
islatravirHIV-1
Phase 2
GSK2838232HIV-1
Phase 2
cobicistatHIV-1
Approved (other)
Japan
vorinostatHIV-1
Phase 2
romidepsinHIV-1
Phase 2
AMD11070HIV-1
Phase 2
MethotrexateHIV-1
Phase 2
amdoxovirHIV-1
Phase 2
GSK3640254HIV-1
Phase 2
GSK3532795HIV-1
Phase 2
Tenofovir disoproxilHIV-1
FDA approved
FDAJapanChina
Adefovir dipivoxilHIV-1
FDA approved
FDAJapan
LenacapavirHIV-1
FDA approved
FDAEMAJapan
AdefovirHIV-1Inhibits viral DNA synthesis
Phase 2
Viral RT
AlisporivirHIV-1
Preclinical
Human CYPs
AmprenavirHIV-1Protease inhibitor
FDA approved
FDAJapan
Viral protease
AtazanavirHIV-1Protease inhibitor
FDA approved
FDAJapanRussia
Viral protease
AzacitidineHIV-1Nucleoside analog DNA methyl transferase inhibitor
Preclinical
Viral RT
AzithromycinHIV-1
Preclinical
Human (multiple)
Showing 1 to 25 of 106 results
Page 1 of 5